S&P 500   4,338.88 (+0.29%)
DOW   34,086.77 (-0.22%)
QQQ   343.14 (+0.60%)
AAPL   166.19 (+4.38%)
MSFT   300.84 (+0.33%)
FB   295.90 (+0.43%)
GOOGL   2,599.26 (+0.74%)
AMZN   2,783.54 (-0.33%)
TSLA   841.91 (+1.55%)
NVDA   220.34 (+0.41%)
BABA   111.60 (-0.17%)
NIO   20.24 (-4.12%)
AMD   103.53 (+0.91%)
CGC   6.99 (+2.04%)
MU   77.11 (-2.05%)
GE   89.52 (-0.42%)
T   24.44 (+1.33%)
F   19.32 (-1.18%)
DIS   134.75 (-0.49%)
AMC   14.23 (-2.00%)
PFE   53.94 (+1.07%)
ACB   3.82 (+0.79%)
BA   183.92 (-3.07%)
S&P 500   4,338.88 (+0.29%)
DOW   34,086.77 (-0.22%)
QQQ   343.14 (+0.60%)
AAPL   166.19 (+4.38%)
MSFT   300.84 (+0.33%)
FB   295.90 (+0.43%)
GOOGL   2,599.26 (+0.74%)
AMZN   2,783.54 (-0.33%)
TSLA   841.91 (+1.55%)
NVDA   220.34 (+0.41%)
BABA   111.60 (-0.17%)
NIO   20.24 (-4.12%)
AMD   103.53 (+0.91%)
CGC   6.99 (+2.04%)
MU   77.11 (-2.05%)
GE   89.52 (-0.42%)
T   24.44 (+1.33%)
F   19.32 (-1.18%)
DIS   134.75 (-0.49%)
AMC   14.23 (-2.00%)
PFE   53.94 (+1.07%)
ACB   3.82 (+0.79%)
BA   183.92 (-3.07%)
S&P 500   4,338.88 (+0.29%)
DOW   34,086.77 (-0.22%)
QQQ   343.14 (+0.60%)
AAPL   166.19 (+4.38%)
MSFT   300.84 (+0.33%)
FB   295.90 (+0.43%)
GOOGL   2,599.26 (+0.74%)
AMZN   2,783.54 (-0.33%)
TSLA   841.91 (+1.55%)
NVDA   220.34 (+0.41%)
BABA   111.60 (-0.17%)
NIO   20.24 (-4.12%)
AMD   103.53 (+0.91%)
CGC   6.99 (+2.04%)
MU   77.11 (-2.05%)
GE   89.52 (-0.42%)
T   24.44 (+1.33%)
F   19.32 (-1.18%)
DIS   134.75 (-0.49%)
AMC   14.23 (-2.00%)
PFE   53.94 (+1.07%)
ACB   3.82 (+0.79%)
BA   183.92 (-3.07%)
S&P 500   4,338.88 (+0.29%)
DOW   34,086.77 (-0.22%)
QQQ   343.14 (+0.60%)
AAPL   166.19 (+4.38%)
MSFT   300.84 (+0.33%)
FB   295.90 (+0.43%)
GOOGL   2,599.26 (+0.74%)
AMZN   2,783.54 (-0.33%)
TSLA   841.91 (+1.55%)
NVDA   220.34 (+0.41%)
BABA   111.60 (-0.17%)
NIO   20.24 (-4.12%)
AMD   103.53 (+0.91%)
CGC   6.99 (+2.04%)
MU   77.11 (-2.05%)
GE   89.52 (-0.42%)
T   24.44 (+1.33%)
F   19.32 (-1.18%)
DIS   134.75 (-0.49%)
AMC   14.23 (-2.00%)
PFE   53.94 (+1.07%)
ACB   3.82 (+0.79%)
BA   183.92 (-3.07%)
NASDAQ:TELA

TELA Bio News Headlines

$11.15
-0.20 (-1.76%)
(As of 01/28/2022 10:16 AM ET)
Add
Compare
Today's Range
$11.15
$11.15
50-Day Range
$11.35
$13.70
52-Week Range
$11.03
$18.00
Volume
2 shs
Average Volume
44,846 shs
Market Capitalization
$161.72 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
1.66
Get TELA Bio News Delivered to You Automatically

Sign up to receive the latest news and ratings for TELA and its competitors with MarketBeat's FREE daily newsletter.

Media Mentions By Week

TELA Bio Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

TELA
News Sentiment

1.15

0.27

Average
Medical
News Sentiment

Media Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

TELA Articles
This Week

3

1

TELA Articles
Average Week



TELA Bio (NASDAQ:TELA) News Headlines Today

SourceHeadline
insidertrades.com logoTELA Bio, Inc. (NASDAQ:TELA) Insider Buys $58,400.00 in Stock
insidertrades.com - January 26 at 12:15 PM
MarketBeat logoComparing TELA Bio (NASDAQ:TELA) and Vapotherm (NYSE:VAPO)
americanbankingnews.com - January 23 at 10:18 PM
insidertrades.com logoEw Healthcare Partners Fund 2, Purchases 567,467 Shares of TELA Bio, Inc. (NASDAQ:TELA) Stock
insidertrades.com - January 19 at 3:09 PM
insidertrades.com logoEw Healthcare Partners Fund 2, Acquires 5,000 Shares of TELA Bio, Inc. (NASDAQ:TELA) Stock
insidertrades.com - January 14 at 6:34 PM
nasdaq.com logoTELA Bio, Inc. Common Stock (TELA)
nasdaq.com - January 12 at 10:55 PM
insidertrades.com logoEw Healthcare Partners Fund 2, Acquires 1,409 Shares of TELA Bio, Inc. (NASDAQ:TELA) Stock
insidertrades.com - January 12 at 6:46 PM
finance.yahoo.com logoTELA Bio (NASDAQ:TELA) shareholders have endured a 26% loss from investing in the stock a year ago
finance.yahoo.com - December 8 at 3:20 PM
nasdaq.com logoInvestors in TELA Bio (NASDAQ:TELA) have unfortunately lost 24% over the last year
nasdaq.com - November 13 at 8:07 AM
finance.yahoo.com logoTELA Bio, Inc. (TELA) Q3 2021 Earnings Call Transcript
finance.yahoo.com - November 11 at 12:34 PM
finance.yahoo.com logoTELA Bio Reports Strong Third Quarter 2021 Revenues Reflecting Continued Growth Driven by Increased Demand
finance.yahoo.com - November 10 at 8:43 PM
finance.yahoo.com logoTELA Bio, Inc. (TELA) Reports Q3 Loss, Tops Revenue Estimates
finance.yahoo.com - November 10 at 8:43 PM
finance.yahoo.com logoTELA Bio Announces Publication of 12-Month Results from the BRAVO Study with Continued Positive Outcomes Through 24 months
finance.yahoo.com - November 9 at 8:13 AM
finance.yahoo.com logoTELA Bio to Participate in Three Upcoming Conferences
finance.yahoo.com - November 8 at 10:38 AM
finance.yahoo.com logoWill TELA Bio, Inc. (TELA) Report Negative Q3 Earnings? What You Should Know
finance.yahoo.com - November 3 at 7:28 PM
finance.yahoo.com logoTELA Bio and Next Science Enter into Exclusive Distribution Agreement in the Plastic Reconstructive Market for Advanced Anti-Biofilm Surgical Wash
finance.yahoo.com - November 1 at 11:09 AM
finance.yahoo.com logoTELA Bio to Announce Third Quarter 2021 Financial Results
finance.yahoo.com - October 27 at 6:58 PM
marketwatch.com logoTela Bio Taps Roberto Cuca as Operating and Financial Chief
marketwatch.com - September 27 at 2:57 PM
benzinga.com logoHow Bad Are TELA Bio's Earnings? | Return On Capital Employed
benzinga.com - September 27 at 2:57 PM
nasdaq.com logoRoberto Cuca To Be TELA Bio's New CFO And COO
nasdaq.com - September 27 at 9:56 AM
finance.yahoo.com logoTELA Bio Appoints Roberto Cuca as Chief Operating Officer and Chief Financial Officer
finance.yahoo.com - September 27 at 9:56 AM
finance.yahoo.com logoTELA Bio® Announces New Data on Use of OviTex in a Range of Hernia Repair Applications, Including Novel ReBAR (Reinforced Biologic Augmented Repair) Technique
finance.yahoo.com - September 13 at 8:16 AM
finance.yahoo.com logoTELA Bio's OviTex® Reinforced Tissue Matrix to be Featured in Three Presentations at SAGES 2021
finance.yahoo.com - August 16 at 9:10 AM
nasdaq.com logoAnalyst Estimates: Here's What Brokers Think Of TELA Bio, Inc. (NASDAQ:TELA) After Its Second-Quarter Report
nasdaq.com - August 14 at 8:36 PM
msn.com logoBRIEF-Tela Bio Sees FY Revenue Up 54 To 65 Percent
msn.com - August 12 at 6:40 AM
nasdaq.com logoTELA Bio, Inc. (TELA) Reports Q2 Loss, Tops Revenue Estimates
nasdaq.com - August 12 at 6:40 AM
fool.com logoTELA Bio, Inc. (TELA) Q2 2021 Earnings Call Transcript
fool.com - August 12 at 2:39 AM
benzinga.com logoEarnings Outlook For TELA Bio
benzinga.com - August 10 at 12:10 PM
finance.yahoo.com logoTELA Bio to Participate in Canaccord Genuity’s 41st Annual Growth Conference
finance.yahoo.com - August 3 at 9:18 AM
finance.yahoo.com logoTELA Bio to Announce Second Quarter 2021 Financial Results
finance.yahoo.com - July 28 at 9:36 AM
finanznachrichten.de logoTELA Bio, Inc.: NHS Surgeon First in Europe to Implant TELA Bio's OviTex LPR Reinforced Tissue Matrix
finanznachrichten.de - July 24 at 12:56 AM
benzinga.com logoTELA Bio Highlights NHS Surgeon First In Europe To Implant Co's OviTex LPR Reinforced Tissue Matrix
benzinga.com - July 23 at 7:56 PM
feeds.benzinga.com logoNHS Surgeon First in Europe to Implant TELA Bio's OviTex® LPR Reinforced Tissue Matrix
feeds.benzinga.com - July 21 at 9:00 AM
finance.yahoo.com logoTELA Bio to Participate in Upcoming JMP Securities Life Sciences Conference
finance.yahoo.com - June 14 at 7:41 AM
nz.finance.yahoo.com logoTELA Bio Names Marissa Conrad as Vice President of Clinical and Regulatory Affairs
nz.finance.yahoo.com - May 25 at 8:52 AM
finance.yahoo.com logoTELA Bio Names Marissa Conrad as Vice President of Clinical and Regulatory Affairs
finance.yahoo.com - May 25 at 8:52 AM
benzinga.com logoROCE Insights For TELA Bio
benzinga.com - May 24 at 12:58 PM
finance.yahoo.com logoTELA Bio to Participate in Upcoming Investor Conferences
finance.yahoo.com - May 21 at 8:31 AM
marketwatch.com logoTELA Bio Initiates BRAVO II Study of OviTex(R) for the Robotic Repair of Ventral Hernias
marketwatch.com - May 20 at 8:58 AM
finance.yahoo.com logoTELA Bio Initiates BRAVO II Study of OviTex® for the Robotic Repair of Ventral Hernias
finance.yahoo.com - May 19 at 8:27 AM
msn.com logoBRIEF-TELA Bio Posts Q1 Loss Per Share Of $0.56
msn.com - May 14 at 7:25 AM
finance.yahoo.com logoTELA Bio Announces First Quarter 2021 Financial Results
finance.yahoo.com - May 14 at 7:25 AM
finance.yahoo.com logoTELA Bio, Inc. (TELA) Reports Q1 Loss, Tops Revenue Estimates
finance.yahoo.com - May 14 at 7:25 AM
finance.yahoo.com logoTELA Bio, Inc. (TELA) Q1 2021 Earnings Call Transcript
finance.yahoo.com - May 14 at 7:25 AM
nasdaq.com logoIs TELA Bio (NASDAQ:TELA) Weighed On By Its Debt Load?
nasdaq.com - May 11 at 6:23 PM
finance.yahoo.com logoTELA Bio, Inc. (TELA) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
finance.yahoo.com - May 6 at 7:06 PM
finance.yahoo.com logoTELA Bio Inc. (TELA) Q4 2020 Earnings Call Transcript
finance.yahoo.com - May 3 at 1:35 PM
finance.yahoo.com logoTELA Bio to Announce First Quarter 2021 Financial Results
finance.yahoo.com - April 29 at 8:13 PM
finance.yahoo.com logoRecap: TELA Bio Q4 Earnings
finance.yahoo.com - March 27 at 1:03 PM
seekingalpha.com logoTELA Bio Inc.'s (TELA) CEO Antony Koblish on Q4 2020 Results - Earnings Call Transcript
seekingalpha.com - March 26 at 10:30 AM
seekingalpha.com logoTELA Bio EPS misses by $0.07, beats on revenue
seekingalpha.com - March 26 at 1:17 AM
Get TELA Bio News Delivered to You Automatically

Sign up to receive the latest news and ratings for TELA and its competitors with MarketBeat's FREE daily newsletter.

This page was last updated on 1/28/2022 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.